Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 5, 1997, Pages 507-516

  Wun, Ted ^a   Paglieroni, Teresa ^b   Tablin, Fern ^b   Welborn, Jeanna ^b   Nelson, Karen ^b   Cheung, Anthony ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031147997     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90005-6     Document Type: Article

References (56)

1. Powars D, Chan LS, Schroeder WA. The variable expression of sickle cell diseases is genetically determined. Semin Hematol 1990;4:360-76.
2. Platt OS, Branbilla DJ, Rosse WJ, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
3. Francis RB, Johnson CS. Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood 1991;77:1405-14.
4. Platt OS. Easing the suffering caused by sickle cell disease (ed). N Engl J Med 1994;330:783-4.
5. Lipowsky HH, Sheikh NU, Katz DM. Intravital microscopy of capillary hemodynamics in sickle cell disease. J Clin Invest 1987;80:117-27.
6. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. N Engl J Med 1980;302:992-5.
7. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 1972;287:846-9.
8. Merkel KHH, Ginsberg PL, Parker JC, Post MJD. Cerebrovascular disease in sickle cell anemia: a clinical, pathological, and radiological correlation. Stroke 1978;9:45-52.
9. Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984;63:162-9.
10. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathogical study. Ann Neurol 1986;20:684-90.
11. Charache S, Page DL. Infarction of bone marrow in the sickle cell disorders. Ann Intern Med 1967;67:1195-200.
12. Hatch FE, Crowe LR, Miles DE, Young JP, Portner ME. Altered vascular reactivity in sickle hemoglobinopathy. A possible protective factor from hypertension. Am J Hypertens 1989;2:2-8.
13. Haupt HM, Moore GW, Bauer TW, Hutchins GM. The lung in sickle cell disease. Chest 1982;81:332-7.
14. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle cell erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 1993; 81:2137-43.
15. Kasschau MR, Barabino GA, Bridges KR, Golan DE. Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 1996;87:771-80.
16. Swerlick RA, Eckman JR, Kumar A, Jeitler M, Wick TM. α4β1-integrin expression of sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 1993;82:1891-9.
17. Joneckis CC, Ackley RL, Orringer EP, Wayner EA, Parise LV. Integrin α4β1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 1993; 82:3548-55.
18. Kumar A, Eckman JR, Swerlick RA, Wick TM. Sickle erythrocytes stimulated with phorbol ester adhere to endothelium via activated α4β1 integrin on sickle reticulocytes and fibronectin on endothelium. Blood 1994;84(suppl 1):408. Abstract.
19. Mehta P, Mehta J. Abnormalities of platelet aggregation in sickle cell disease. J Pediatr 1980;96:209-13.
20. Buchanan GR, Holtkamp CA. Platelet aggregation, malondialdehyde generation and production time in children with sickle cell anemia. Thromb Haemost 1981;46:690-3.
21. Mehta P. Significance of plasma β-thromboglobulin in patients with sickle cell disease. J Pediatr 1980;97:941-4.
22. Adamides S, Konstantopoulos K, Toumbis M, Douratsos D, Travlou A, Kasfiki A. A study of β-thromboglobulin and platelet factor-4 levels in steady state sickle cell patients. Blut 1990;61:245-7.
23. Beurling-Harbury C, Schade SG. Platelet activation during pain crisis in sickle cell anemia patients. Am J Hematol 1989;31:237-41.
24. Kuranstin-Mills J, Ibe BO, Raj JU, Siegel RS, Lessin LS. Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. Blood 1991;78(suppl 1):217. Abstract.
25. Tomer A, Eckman JR, Vroon DH. Platelet activation and procoagulant activity in sickle cell disease. Blood 1992; 80(suppl 1):11. Abstract.
26. Tomer A, Harker LA, Eckman JR. Circulating platelets and red cells promote in vivo thrombogenic activity in sickle cell disease. Blood 1994;84(suppl 1):412. Abstract.
27. Hebbel RP, Steinberg MH, Mosher D. Plasma and platelet thrombospondin in sickle cell disease. Clin Res 1993;41:762. Abstract.
28. Browne PV, Mosher DF, Steinberg MH, Hebbel RP. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol 1996;51:296-301.
29. Valles J, Santos MT, Aznar J, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 1991;78:154-62.
30. Santos MT, Valles J, Marcus AJ, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 1991;87:571-80.
31. Antonucci R, Walker R, Herion J, Orringer E. Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 1990;34:44-8.
32. James TN, Riddick L, Massing GK. Sickle cell and sudden death: morphologic abnormalities of the cardiac conduction system. J Lab Clin Med 1994;32:534-40.
33. Wun T, Paglieroni T, Sazama K, Holland P. Detection of plasmapheresis-induced platelet activation using monoclonal antibodies. Tranfusion 1992;32:534-40.
34. Wun T, Paglieroni T, Holland P. Prolonged circulation of activated platelets following plasmapheresis. J Clin Apheresis 1994;96:10-16.
35. Wun T, Paglieroni T, Lachant NA. Desmopressin stimulates P-selectin expression on human platelets in vitro. J Lab Clin Med 1995;125:401-9.
36. Wun T, Paglieroni T, Lachant NA. Physiologic concentrations of arginine vasopressin activate human platelets in vitro. Brit J Haematol 1996;92:968-72.
37. Ault KA, Rinder HM, Mitchell JG, Rinder CG, Lambrew CT, Hillman RS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1988;10:448-55.
38. Pedigo M, Wun T, Paglieroni T. Removal by white cell-reduction filters of activated platelets expressing CD62. Transfusion 1993;33:930-5.
39. Metzelaar MJ, Korteweg J. Sixma JJ, Nieuwenhius HK. Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass. J Lab Clin Med 1993;121:579-87.
40. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992;119:334-45.
41. Howard MA, Coghlan M, David R. Pfueller SL. Coagulation activities of plasma microparticles. Thromb Res 1988;50:145-56.
42. Allan D, Limbrick AR, Thomas P, Westerman MP. Microvesicles from sickle erythrocytes and their relation to irreversible sickling. Brit J Haematol 1981;47:383-90.
43. Padilla F, Bromberg PA, Jensen WN. The sickle-unsickle cycle: a cause of cell fragmentation leading to permanently deformed cells. Blood 1973;41:653-60.
44. Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood 1991;77:887-95.
45. Francis RB. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis 1989;19: 105-11.
46. Green D, Scott JP. Is sickle cell crisis a thrombotic event? Am J Hematol 1986;23:317-21.
47. Kuypers FA, Styles L, Yee M, Schott MA, Lubin BH, Vichinsky E. Increased plasma levels of fragment 1.2 correlate with loss of phospholipid asymmetry in subpopulations of sickle cells. Blood 1995;86(suppl 1):298. Abstract.
48. Hurlet-Jensen A, Morris V, Seaman C, Martin B, Piomelli S. Protein C (PC), protein S (PS), prothrombin fragment 1+2 (F1.2) in patients with sickle cell disease (SCD): effect of transfusion therapy and hemoglobin concentration. Blood 1995;86(suppl 1):298. Abstract.
49. Silijander P, Carpen O, Lassila R. Platelet-derived micropartides associate with fibrin during thrombosis. Blood 1996;87: 4651-63.
50. Kuypers FA, van den Berg JJM, Lubin BH. Membrane lipids and vesiculation. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:139-52.
51. Ruoslahti E. Integrins. J Clin Invest 1991;87:1-5.
52. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549-54.
53. Hynes RO. Intergins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
54. Charo IF, Keiffer N, Phillips DR. Platelet membrane glycoproteins. In: Colman RW, Hirsch J, Marder VJ, editors. Hemostasis and thrombosis: basic principles and clinical practice (3rd ed). Philadelphia: JB Lippincott Company, 1994:489-507.
55. Sugihara K, Sugihara T, Mohandas N, Hebbel RP. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 1992;80:2634-42.
56. Hofstra TC, Kalra VK, Meiselman HJ, Coates TD. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood 1996;87: 4440-7.